Sidley Austin has advised Werewolf Therapeutics. Cooley has advised Ambros Therapeutics. Latham & Watkins has advised the placement agents. Werewolf Therapeutics, Inc. (NASDAQ: HOWL) and Ambros...
Werewolf and Ambros Therapeutics Announce All-Stock Merger and $150 Million Private Placement
Artios Pharma Raises $115 Million in Series D Financing to Advance Clinical Programs
Cooley has advised Artios Pharma, while Sidley and Brown Rudnick have advised RA Capital Management. DLA Piper has advised Pfizer Venture. Artios Pharma Limited has closed...
Eli Lilly Announces Acquisition of Adverum Biotechnologies for Up to $1.3 Billion
Ropes & Gray has advised Eli Lilly and Company, and Cooley has advised Adverum Biotechnologies, Inc. Eli Lilly and Company has entered into a definitive agreement...
Jazz Pharmaceuticals’ $935 Million Acquisition of Chimerix
Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Jazz, while Skadden and Cooley are advising Chimerix on the deal. Jazz Pharmaceuticals plc and...
2045’s $4.2 Million Pre-Seed Funding Round
Cooley advised 2045 on the financing. 2045, an exclusive membership network for influential professionals of color, announced its launch and $4.2 million pre-seed financing. Benchstrength led the...